Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Current Assets (2023 - 2026)

Translational Development Acquisition's Current Assets history spans 4 years, with the latest figure at $75316.0 for Q1 2026.

  • On a quarterly basis, Current Assets fell 81.87% to $75316.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $75316.0, a 81.87% decrease, with the full-year FY2025 number at $39465.0, down 93.93% from a year prior.
  • Current Assets came in at $75316.0 for Q1 2026, up from $39465.0 in the prior quarter.
  • The five-year high for Current Assets was $650233.0 in Q4 2024, with the low at $2021.0 in Q4 2023.
  • Historically, Current Assets has averaged $202730.9 across 4 years, with a median of $80582.0 in 2025.
  • Biggest five-year swings in Current Assets: surged 32073.82% in 2024 and later plummeted 93.93% in 2025.
  • Year by year, Current Assets stood at $2021.0 in 2023, then skyrocketed by 32073.82% to $650233.0 in 2024, then crashed by 93.93% to $39465.0 in 2025, then soared by 90.84% to $75316.0 in 2026.
  • Business Quant data shows Current Assets for TDAC at $75316.0 in Q1 2026, $39465.0 in Q4 2025, and $80582.0 in Q3 2025.